amphetamine has been researched along with cannabidiol in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 4 (40.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Burton, P; Mechoulam, R; Parker, LA; Sorge, RE; Yakiwchuk, C | 1 |
Chagas, MH; Crippa, JA; Dal-Pizzol, F; de Souza, B; Dursun, S; Elias, G; Hallak, JE; Kapczinski, F; Petronilho, F; Quevedo, J; Trzesniak, C; Tumas, V; Valvassori, SS; Zuardi, AW | 1 |
Del-Bel, EA; Gomes, FV; Guimarães, FS; Issy, AC; Pedrazzi, JF | 1 |
de Oliveira, C; Laviolette, SR; Loureiro, M; Renard, J; Rosen, LG; Rushlow, WJ; Schmid, S; Zunder, J | 1 |
Cosenza, A; Di Gaudio, F; Fanara, S; Maida, CM; Piscionieri, D; Viviani, G | 1 |
Burger, ME; da Rosa, JLO; Metz, VG; Milanesi, LH; Pase, CS; Rossato, DR | 1 |
Crippa, JAS; Del Bel, E; Guimarães, FS; Joca, SRL; Pedrazzi, JFC; Sales, AJ | 1 |
Burger, ME; da Rosa, JLO; Metz, VG; Pase, CS; Rossato, DR | 1 |
Breuer, A; Colodete, DAE; Cortez, I; Del-Bel, EA; Fogaça, MV; Gomes, FV; Guimarães, FS; Mechoulam, R; Pedrazzi, JFC; Silva, NR | 1 |
10 other study(ies) available for amphetamine and cannabidiol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Topics: Amphetamine; Animals; Cannabidiol; Cocaine; Conditioning, Operant; Dronabinol; Extinction, Psychological; Learning; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2004 |
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania.
Topics: Amphetamine; Animals; Antimanic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Cannabidiol; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Hippocampus; Hyperkinesis; Male; Motor Activity; Oxidative Stress; Prefrontal Cortex; Protein Carbonylation; Rats; Rats, Wistar | 2011 |
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine.
Topics: Amphetamine; Animals; Benzamides; Cannabidiol; Carbamates; Inhibition, Psychological; Male; Mice; Nucleus Accumbens; Prepulse Inhibition; Reflex, Startle | 2015 |
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.
Topics: Amphetamine; Animals; Behavior, Animal; Cannabidiol; Central Nervous System Stimulants; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Limbic System; Male; Motor Activity; Neural Pathways; Neurons; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reflex, Startle; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases | 2016 |
Occurrence of illicit drugs in two wastewater treatment plants in the South of Italy.
Topics: Amphetamine; Amphetamines; Cannabidiol; Cocaine; Dronabinol; Drug Combinations; Humans; Illicit Drugs; Methamphetamine; Pyrrolidines; Sicily; Substance Abuse Detection; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2018 |
Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain; Cannabidiol; Central Nervous System Stimulants; Dopamine; Rats; Rats, Wistar; Receptors, Dopamine D2; Recurrence | 2021 |
Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Cannabidiol; Clozapine; Dizocilpine Maleate; DNA Methylation; Epigenesis, Genetic; Hallucinogens; Male; Mice; Neuroprotective Agents; Prefrontal Cortex; Prepulse Inhibition; Reflex, Startle; Schizophrenia; Sensory Gating; Time Factors; Ventral Striatum | 2021 |
Cannabidiol treatment prevents drug reinstatement and the molecular alterations evoked by amphetamine on receptors and enzymes from dopaminergic and endocannabinoid systems in rats.
Topics: Amphetamine; Animals; Cannabidiol; Dopamine; Endocannabinoids; Rats; Recurrence | 2022 |
Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Cannabidiol; Cannabinoids; Catalepsy; Dronabinol; Male; Mice | 2023 |